Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (61-70 of 221) with videos related to

Pageof 23
Sort By:
The Journal of Antimicrobial Chemotherapy|June 7, 2021
Precision dosing of vancomycin: in defence of AUC-guided therapy in childrenMark E Murphy, Sonya Tang Girdwood, Jennifer L Goldman, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantationSteven M Trifilio, Paul R Yarnold, Marc H Scheetz, et al.
Open Forum Infectious Diseases|December 18, 2020
Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 StudyJiajun Liu, Steven Y C Tong, Joshua S Davis, et al.
Journal of Global Antimicrobial Resistance|February 13, 2018
Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infectionsMilena M McLaughlin, Cristina Miglis, Erik Skoglund, et al.
The Journal of Applied Laboratory Medicine|June 4, 2021
Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in SerumMatthew W Bjergum, Erin F Barreto, Marc H Scheetz, et al.
Pharmacotherapy|December 15, 2022
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendationKayla Antosz, Sarah Battle, Jack Chang, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infectionsJohn S Esterly, Milena Griffith, Chao Qi, et al.
BMC Infectious Diseases|January 17, 2014
Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomesMilena M McLaughlin, M Renee Advincula, Michael Malczynski, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat ModelJack Chang, Gwendolyn M Pais, Kimberly Valdez, et al.
Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Effects on patient care caused by drug shortages: a surveyMilena McLaughlin, Despina Kotis, Kenneth Thomson, et al.
Pageof 23

Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
The Journal of Antimicrobial Chemotherapy|June 7, 2021
Precision dosing of vancomycin: in defence of AUC-guided therapy in childrenMark E Murphy, Sonya Tang Girdwood, Jennifer L Goldman, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantationSteven M Trifilio, Paul R Yarnold, Marc H Scheetz, et al.
Open Forum Infectious Diseases|December 18, 2020
Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 StudyJiajun Liu, Steven Y C Tong, Joshua S Davis, et al.
Journal of Global Antimicrobial Resistance|February 13, 2018
Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infectionsMilena M McLaughlin, Cristina Miglis, Erik Skoglund, et al.
The Journal of Applied Laboratory Medicine|June 4, 2021
Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in SerumMatthew W Bjergum, Erin F Barreto, Marc H Scheetz, et al.
Pharmacotherapy|December 15, 2022
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendationKayla Antosz, Sarah Battle, Jack Chang, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infectionsJohn S Esterly, Milena Griffith, Chao Qi, et al.
BMC Infectious Diseases|January 17, 2014
Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomesMilena M McLaughlin, M Renee Advincula, Michael Malczynski, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat ModelJack Chang, Gwendolyn M Pais, Kimberly Valdez, et al.
Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Effects on patient care caused by drug shortages: a surveyMilena McLaughlin, Despina Kotis, Kenneth Thomson, et al.
Pageof 23